ReviewThe Indian journal of medical research2010
Strategies for initial management of hypertension.
Review in The Indian journal of medical research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04515095 (A Safety and Feasibility Study of Water-only Fasting and Refeeding for Treatment of Stage 1 and 2 Hypertensive Patients), which is not on this map. Cited by 33 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Safety and Feasibility Study of Water-only Fasting and Refeeding for Treatment of Stage 1 and 2 Hypertensive Patients
Who cites it
33 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.
- Effect of leisure-time physical activity on blood pressure in people with hypertension: a systematic review and meta-analysis.Scientific reports · 2023Pooled it
- Beyond genetics: how environmental stressors drive pediatric hypertension risk.Pediatric nephrology (Berlin, Germany) · 2026Review
- The In Vitro Multifaceted Biological Activity of Catechins in Relation to Their Oxidation Potentials.Molecules (Basel, Switzerland) · 2026Article
- Multifaceted Biological Activity of Selected FlavoneInternational journal of molecular sciences · 2025Article
- Angiotensin-Converting Enzyme Inhibitory Activity of Selected Phenolic Acids, Flavonoids, TheirMetabolites · 2025Article
- Multifaceted Biological Activity of Rutin, Quercetin, and Quercetin's Glucosides.Molecules (Basel, Switzerland) · 2025Article
- The role of Kolaviron, a bioflavonoid fromHeliyon · 2024Article
- Differentials in lifestyle practices and determinants among hypertensive adults from three geopolitical zones in Nigeria.The Pan African medical journal · 2024Article
- The effect of results-based motivating system on metabolic risk factors of non-communicable diseases: A field trial study.PloS one · 2024Article
- Effectiveness of a hypertension management protocol in rural Haitian adults and pregnant women.Dialogues in health · 2023Article
- Insulin Resistance and Hypertension: Mechanisms Involved and Modifying Factors for Effective Glucose Control.Biomedicines · 2023Review
- A Status Review on Health-Promoting Properties and Global Regulation of Essential Oils.Molecules (Basel, Switzerland) · 2023Review
- Losartan as an ACE inhibitor: a description of the mechanism of action through quantum biochemistry.RSC advances · 2022Article
- Association of adherence measured by self-reported pill count with achieved blood pressure level in hypertension patients: a cross-sectional study.Clinical hypertension · 2022Article
- Effect of leisure-time physical activity in controlling hypertension: a systematic review and meta-analysis protocol.BMJ open · 2021Article
- Administration with Quinoa Protein Reduces the Blood Pressure in Spontaneously Hypertensive Rats and Modifies the Fecal Microbiota.Nutrients · 2021Article
- Factors associated with self-efficacy in patients with hypertension: a cross-sectional study from Palestine.Journal of health, population, and nutrition · 2021Article
- Impact of the 2017 ACC/AHA guidelines on the prevalence of hypertension among Indian adults: Results from a cross-sectional survey.International Journal of Cardiology. Hypertension · 2020Article
- Current Evidence to Propose Different Food Supplements for Weight Loss: A Comprehensive Review.Nutrients · 2020Review
- Adherence to Hypertension Medications and Lifestyle Recommendations among Underserved African American Middle-Aged and Older Adults.International journal of environmental research and public health · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High blood pressure (BP) is a major public health problem in India and its prevalence is rapidly increasing among urban and rural populations. Reducing systolic and diastolic BP can decrease cardiovascular risk and this can be achieved by non-pharmacological (lifestyle measures) as well as pharmacological means. Lifestyle changes should be the initial approach to hypertension management and include dietary interventions (reducing salt, increasing potassium, alcohol avoidance, and multifactorial diet control), weight reduction, tobacco cessation, physical exercise, and stress management. A number of pharmaceutical agents, well evidenced by large randomized clinical trials, are available for initial treatment of high BP. These include older molecules such as thiazide diuretics and beta-blocking agents and newer molecules, dihydropyridine calcium channel blockers (CCB), angiotensin converting enzyme (ACE) inhibitors, and angiotensin receptor blockers (ARB). In view of the recent clinical trials data, some international guidelines suggest that CCB, ACE inhibitors or ARB and not beta-blockers or diuretics should be the initial therapy in hypertension management. Comprehensive hypertension management focuses on reducing overall cardiovascular risk by lifestyle measures, BP lowering and lipid management and should be the preferred initial treatment approach.
Indexed as
Identifiers
21150005PMC3028941W2140850165What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.